The International Society for Pharmaceutical Engineering (ISPE) launched its philanthropic division, the ISPE Foundation, to support industry demands.
On June 19, 2018, the International Society for Pharmaceutical Engineering (ISPE) announced the launch of its philanthropic arm, ISPE Foundation.
ISPE states that the new foundation will support its members and the pharmaceutical industry to address industry demands. The foundation will seek funding to support a range of initiatives, including the ISPE Travel Grant Program. Under this program, students and young professionals will receive financial support to further their professional development and contribute to building pharma’s future workforce.
The foundation will also support the group’s Women in Pharma program, which provides professional training and education to foster mentorship and networking for women and ethnically diverse people.
Another focus of the foundation is to translate ISPE’s industry guides to the global workforce through its Emerging Markets Knowledge Exchange and to train global regulators in industry best practices through its Global Training and Harmonization Fund.
Source: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.